Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis.

Current therapy for toxoplasmosis with a synergistic combination of pyrimethamine plus sulfadiazine or pyrimethamine plus clindamycin is not always efficacious and is frequently discontinued due to intolerable toxic effects in immunocompromised individuals, particularly those with AIDS. Trovafloxaci...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Khan, A A, Slifer, T, Araujo, F G, Polzer, R J, Remington, J S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1997
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163821/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9145840/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.5.893
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!